SARS-CoV-2 Viral Variants—Tackling a Moving Target

Zhang, Emergence of a novel SARS-CoV-2 strain in Southern California., JAMA

Korber, 2020, Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus., Cell, 182, 812, 10.1016/j.cell.2020.06.043

Yurkovetskiy, 2020, Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant., Cell, 183, 739, 10.1016/j.cell.2020.09.032

Hou, 2020, SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo., Science, 370, 1464, 10.1126/science.abe8499

Nextstrain. Accessed February 8, 2021. https://nextstrain.org/

PANGO lineages. Accessed February 8, 2021. https://cov-lineages.org

Rambaut? A, Loman? N, Pybus? O, ; COVID-19 Genomics Consortium UK. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological.org. Posted December 18, 2020. Accessed January 3, 2021. https://virological.org/t/preliminary-genomic-characterisation-of-anemergent-sars-cov-2-lineage-in-the-uk-definedby-a-novel-set-of-spike-mutations/563

Horby P, Huntley C, Davies N, et al. Paper from the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) on new coronavirus (COVID-19) variant B.1.1.7. Posted January 21, 2021. Accessed February 8, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/955239/NERVTAG_paper_on_variant_of_concern__VOC__B.1.1.7.pdf

Tegally? H, Wilkinson? E, Giovanetti? M, . Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa.? medRxiv. Preprint published online December 22, 2020. doi:10.1101/2020.12.21.20248640

Wibmer? CK, Ayres? F, Hermanus? T, . SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.? bioRxiv. Preprint published online January 19, 2021. doi:10.1101/2021.01.18.427166

Wu? K, Werner? AP, Moliva? JI, . mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants.? bioRxiv. Preprint published online January 25, 2021. doi:10.1101/2021.01.25.427948

Ho? D, Wang? P, Liu? L, . Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization.? Res Sq. Preprint published online January 29, 2021. doi:10.21203/rs.3.rs-155394/v1

Johnson & Johnson announces single-shot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its phase 3 ENSEMBLE trial. Johnson & Johnson. Posted January 29, 2021. Accessed February 8, 2021. https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial

Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK phase 3 trial. Novavax. Posted January 28, 2021. Accessed February 8, 2021. https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3